Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Their solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient, and modern manner. They achieve this by combining over two decades of healthcare domain expertise and fit-forpurpose technology. Their portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies.
They have established client relationships with each of the 20 largest biopharmaceutical companies in the world by revenue for the Financial Year 2023 (Source: Everest Report), having earned more than 69.00% of their total revenue from operations for each of the nine months ended December 31, 2023, and 2022 and the Financial Years 2023, 2022 and 2021 from these 20 customers. As of December 31, 2023, they had a total of 65 active clients (i.e., clients from whom they earned US$0.25 million or more in revenues during the 12 months preceding the relevant date). They had 27 clients from whom they earned between US$1 million and US$10 million in revenues, five clients from whom they earned between US$10 million and US$25 million in revenues, and three clients from whom they earned more than US$25 million in revenues, during the 12 months ended December 31, 2023.
Objects of the Issue
- Repayment/prepayment of indebtedness of one of our Material Subsidiaries, ILSL Holdings, Inc
- Funding the capital expenditure requirements of our Company and one of our Material Subsidiaries, Indegene Inc
- General corporate purposes and inorganic growth.
Indegene IPO Review (Apply or Not)
- Apply
Brokerage Firm IPO Review
- BP Equities (BP Wealth): Apply
- Indsec Securities: Apply
- SBICAP Securities Limited: Apply
- SMIFS Limited: Apply
- Swastika Investmart Ltd: Apply
- Ventura Securities Limited: Apply
Indegene IPO Date & Price Band Details
IPO Open: | May 6, 2024 |
IPO Close: | May 8, 2024 |
IPO Size: | Approx ₹1841.76 Crores |
Fresh Issue: | Approx ₹760 Crores |
Offer for Sale: | Approx ₹1081.76 Crores, 2,39,32,732 Equity shares |
Face Value: | ₹2 Per Equity Share |
IPO Price Band: | ₹430 to ₹452 Per Share |
IPO Listing on: | BSE & NSE |
Retail Quota: | 35% |
QIB Quota: | 50% |
NII Quota: | 15% |
Discount: | N/A |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |
Indegene IPO Market Lot
The Indegene IPO minimum market lot is 33 shares with ₹14,916 application amount. The retail investors can apply up-to 13 lots with 429 shares or ₹193,908 amount.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 33 | ₹14,916 |
Retail Maximum | 13 | 429 | ₹193,908 |
S-HNI Minimum | 14 | 462 | ₹208,824 |
B-HNI Minimum | 68 | 2,244 | ₹1,014,288 |
Indegene IPO Allotment & Listing Dates
The Indegene IPO date is May 6 and the close date is May 8. The Indegene IPO allotment will be finalized on May 9 and the IPO listing on May 13.
Anchor Investors Date: | May 5, 2024 |
IPO Open Date: | May 6, 2024 |
IPO Close Date: | May 8, 2024 |
Basis of Allotment: | May 9, 2024 |
Refunds: | May 10, 2024 |
Credit to Demat Account: | May 10, 2024 |
IPO Listing Date: | May 13, 2024 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Indegene IPO Form
How to apply for the Indegene IPO? You can apply for Indegene IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Indegene IPO in the Invest section. The other option is you can apply for Indegene IPO via IPO forms downloaded via NSE and BSE. Check out the Indegene forms – Click BSE Forms & NSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.
Indegene Company Financial Report
₹ in Crores | |||
Year | Revenue | Expense | PAT |
2021 | ₹996.92 | ₹768.25 | ₹149.41 |
2022 | ₹1690.50 | ₹1417.10 | ₹162.82 |
2023 | ₹2364.10 | ₹2001.05 | ₹266.10 |
Dec 2023 | ₹1969.75 | ₹1644.64 | ₹241.90 |
Indegene IPO Valuation – FY2023
Check Indegene IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
Earning Per Share (EPS): | ₹12.03 per Equity Share |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 25.02% |
Net Asset Value (NAV): | ₹48.10 per Equity Share |
Peer Group
- NA
Company Promoters
- The company is a professionally managed company and does not have an identifiable promoter.
Indegene IPO Registrar
Link Intime India Private Ltd
Phone: +91 81 0811 4949
Email: [email protected]
Website: https://linkintime.co.in/
Indegene IPO Allotment Status Check
Check Indegene IPO allotment status on Linkintime website allotment URL. Click Here
Indegene IPO Lead Managers aka Merchant Bankers
- Kotak Mahindra Capital Company Limited
- Citigroup Global Markets India Private Limited
- J.P. Morgan India Private Limited
- Nomura Financial Advisory and Securities (India) Private Limited
Company Address
Indegene Limited
Aspen Block G4, 3rd Floor, Manyata Embassy Business Park,
Outer Ring Road, Nagawara, Bengaluru 560 045, Karnataka
Phone: +91 80 4674 4567
Email: [email protected]
Website: www.indegene.com
Indegene IPO FAQs
What is Indegene IPO?
When Indegene IPO will open?
What is Indegene IPO Investors Portion?
How to Apply the Indegene IPO?
How to Apply the Indegene IPO through Zerodha?
How to Apply the Indegene IPO through Upstox?
How to Apply the Indegene IPO through Paytm Money?
What is Indegene IPO Size?
What is Indegene IPO Price Band?
What is the Indegene IPO Allotment Date?
What is the Indegene IPO Listing Date?
Note: The Indegene IPO price band and date are officially announced. The IPO grey market premium (Indegene IPO Premium) will be added to the IPO grey market page as it will start).